https://www.selleckchem.com/pr....oducts/l-alpha-phosp
Background Approximately 20% resectable non-small cell lung cancer (NSCLC) patients are treated non-surgically due to various reasons. The aim of the present study was to compare the effectiveness of radiofrequency ablation (RFA) and stereotactic body radiotherapy (SBRT) in patients with stage IA NSCLC who were ineligible for surgery using the surveillance, epidemiology and end-results (SEER) Database. Methods Using the SEER registry, we identified a total of 6,195 IA NSCLC patients who received SBRT or RFA between 2
Like
Comment
Share
